Locoregional therapy as a bridge to liver transplantation for hepatocellular carcinoma within Milan criteria: from a transplant oncology viewpoint

Affiliations

Editorial

Taizo Hibi et al. Hepatobiliary Surg Nutr. 2018 Apr.

. 2018 Apr;7(2):134-135.

doi: 10.21037/hbsn.2018.01.07.

¹ Department of Transplantation and Pediatric Surgery, Kumamoto University Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW. Agopian VG, et al. Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381. Ann Surg. 2017. PMID: 28654545

1. Agopian VG, Harlander-Locke MP, Ruiz RM, et al. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Ann Surg 2017;266:525-35. 10.1097/SLA.0000000000002381 - DOI - PubMed
1. Nathan H, Bridges JF, Schulick RD, et al. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol 2011;29:619-25. 10.1200/JCO.2010.30.8650 - DOI - PMC - PubMed
1. Nathan H, Segev DL, Bridges JF, et al. Influence of nonclinical factors on choice of therapy for early hepatocellular carcinoma. Ann Surg Oncol 2013;20:448-56. 10.1245/s10434-012-2619-5 - DOI - PubMed
1. Song JE, Kim DY. Conventional <i>vs</i> drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma. World J Hepatol 2017;9:808-14. 10.4254/wjh.v9.i18.808 - DOI - PMC - PubMed
1. Salem R, Gordon AC, Mouli S, et al. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. Gastroenterology 2016;151:1155-63.e2. 10.1053/j.gastro.2016.08.029 - DOI - PMC - PubMed